A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells

- Stehn, Justine R., Haass, Nikolas K., Allanson, Munif, Fath, Thomas, Hill, Timothy A., McCluskey, Adam, Schevzov, Galina, Palmer, Stephen J., Hardeman, Edna C., Winlaw, David, Reeve, Vivienne E., Dixon, Ian, Bonello, Teresa, Weninger, Wolfgang, Cripe, Timothy P., Gunning, Peter W., Desouza, Melissa, Kottyan, Gregg, Treutlein, Herbert, Zeng, Jun, Nascimento, Paula R. B. B., Sequeira, Vanessa B., Butler, Tanya L.

A p53-responsive miRNA network promotes cancer cell quiescence

- La, Ting, Liu, Guang Zhi, Guo, Su Tang, Liu, Tao, Thorne, Rick F., Jin, Lei, Zhang, Xu Dong, Farrelly, Margaret, Cole, Nicole, Feng, Yu Chen, Zhang, Yuan Yuan, Sherwin, Simonne K., Yari, Hamed, Tabatabaee, Hessam, Yan, Xu Guang

An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development

- Cullinane, Carleen, Dorow, Donna S., Kansara, Maya, Conus, Nelly, Binns, David, Hicks, Rodney J., Ashman, Leonie Kay, McArthur, Grant A., Thomas, David M.

Antagonists of IGF: Vitronectin Interactions Inhibit IGF-I-Induced Breast Cancer Cell Functions

- Kashyap, Abhishek S., Shooter, Gary K., Hollier, Brett G., Shokoohmand, Ali, McGovern, Jacqui, Sivaramakrishnan, Manaswini, Croll, Tristan I., Cane, Gaëlle, Leavesley, David I., Söderberg, Ola, Upton, Zee

Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma

- Carlino, Matteo S., Gowrishankar, Kavitha, Rizos, Helen, Saunders, Catherine A. B., Pupo, Gulietta M., Snoyman, Stephanie, Zhang, Xu Dong, Saw, Robyn, Becker, Therese M., Kefford, Richard F., Long, Georgina V.

Associations between physical activity and quality of life in a population-based sample of kidney cancer survivors

- Trinh, Linda, Plotnikoff, Ronald C,, Rhodes, Ryan E,, North, Scott, Courneya, Kerry S.

Associations between silicone skin cast score, cumulative sun exposure, and other factors in the Ausimmune study: a multicenter Australian study

- Lucas, Robyn M., Ponsonby, Anne-Louise, Chapman, Caron, Coulthard, Alan, Kilpatrick, Trevor, Dear, Keith, Taylor, Bruce V., Dwyer, Terence, McMichael, Anthony J., Valery, Patricia, Van der Mei , Ingrid, Williams, David, Pender, Michael P.

B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers

- McLachlan, Tabitha, Matthews, William C., Dun, Matthew D., Jackson, Evangeline R., Staudt, Dilana E., Douglas, Alicia M., Findlay, Izac J., Persson, Mika L., Duchatel, Ryan J., Mannan, Abdul, Germon, Zacary P.

Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up

- Mathers, John C., Elliott, Faye, Lindblom, Annika, Morrison, Patrick J., Rashbass, Jem, Ramesar, Raj S., Seppälä, Toni T., Thomas, Huw J. W., Sheth, Harsh J., Pylvänäinen, Kirsi, Reed, Lynn, Borthwick, Gillian M., Macrae, Finlay, Bishop, D. Timothy, Burn, J, Boussioutas, A, Brewer, C, Cook, J, Eccles, D, Ellis, A, Hodgson, SV, Lubinski, J, Maher, ER, Mecklin, Jukka-Pekka, Porteous, MEM, Sampson, J, Scott, Rodney J., Side, L, Bisgaard, ML, Chu, C, Fidalgo, P, Gallinger, S, Homfray, T, Möslein, Gabriela, Hutter, P, Leite, J, MacKay, J, Marks, CG, Miles, A, Murday, V, Oliani, C, Olschwang, S, Segura, PP, Pichert, G, McRonald, Fiona E., Sappino, AP, Tempesta, A, Vasen, HFA, Walpole, I, Langman, C, Shand, B, Bacon, A, Bertario, Lucio, Evans, D. Gareth, Gerdes, Anne-Marie, Ho, Judy W. C.

Characteristics associated with the use of diagnostic prostate biopsy and biopsy outcomes in Australian men

- Chiam, Karen, Bang, Albert, Patel, Manish I., Nair-Shalliker, Visalini, O'Connell, Dianne L., Smith, David P.

Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

- Venneti, Sriram, Kawakibi, Abed Rahman, Ramage, Samuel, Chi, Andrew, Wen, Patrick Y., Arrillaga-Romany, Isabel, Batchelor, Tracy T., Butowski, Nicholas A., Sumrall, Ashley, Shonka, Nicole, Harrison, Rebecca A., de Groot, John, Ji, Sunjong, Mehta, M, Hall, MD, Daghistani, D, Cloughesy, TF, Ellingson, BM, Beccaria, K, Varlet, P, Kim, MM, Umemura, Y, Garton, H, Waszak, Sebastian M., Franson, A, Schwartz, J, Jain, R, Kachman, M, Baum, H, Burant, CF, Mottl, SL, Cartaxo, RT, John, V, Messinger, D, Sweha, StefanR, Qin, T, Peterson, E, Sajjakulnukit, P, Ravi, K, Waugh, A, Walling, D, Ding, Y, Xia, Z, Schwendeman, A, Hawes, D, Mota, Mateus, Yang, F, Judkins, AR, Wahl, D, Lyssiotis, CA, de la Nava, D, Alonso, MM, Eze, A, Spitzer, J, Schmidt, SV, Duchatel, Ryan J., Pun, Matthew, Dun, Matthew D., Cain, JE, Jiang, L, Stopka, SA, Baquer, G, Regan, MS, Filbin, MG, Agar, NYR, Zhao, L, Kumar-Sinha, C, Deogharkar, Akash, Mody, R, Chinnaiyan, A, Kurokawa, R, Pratt, D, Yadav, VN, Grill, J, Kline, C, Mueller, S, Resnick, A, Nazarian, J, Chung, Chan, Allen, JE, Odia, Y, Gardner, SL, Koschmann, C, Tarapore, Rohinton S.

Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: Impact on cell motility

- Gesierich, S., Paret, C., Hildebrand, D., Weitz, J., Zgraggen, K., Schmitz-Winnenthal, F. H., Horejsi, V., Yoshie, O., Herlyn, D., Ashman, Leonie K., Zoller, M.

Contrasting effects of Nutlin-3 on TRAIL- and Docetaxel-induced Apoptosis due to upregulation of TRAIL-R2 and Mcl-1 in human melanoma cells

- Tseng, Hsin-Yi, Jiang, Chen Chen, Croft, Amanda, Thorne, Rick Francis, Yang, Fan, Liu, Hao, Hersey, Peter, Zhang, Xu Dong

Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers

- Glubb, Dylan M., Thompson, Deborah J., Bermisheva, Marina, McNeish, IA, Menon, U, Modugno, F, Moysich, KB, Nevanlinna, H, Odunsi, K, Olsson, H, Orsulic, S, Osorio, A, Palli, D, Bernardini, Marcus Q., Park-Simon, T-W, Pearce, CL, Pejovic, T, Permuth, JB, Podgorska, A, Ramus, SJ, Rebbeck, TR, Riggan, MJ, Risch, HA, Rothstein, JH, Bischof, Katharina, Runnebaum, IB, Scott, RJ, Sellers, TA, Senz, J, Setiawan, VW, Siddiqui, N, Sieh, W, Spiewankiewicz, B, Sutphen, R, Swerdlow, AJ, Bjorge, Line, Szafron, LM, Teo, SH, Thompson, PJ, Thomsen, LCV, Titus, L, Tone, A, Tumino, R, Turman, C, Vanderstichele, A, Edwards, DV, Bodelon, Clara, Vergote, I, Vierkant, RA, Wang, Z, Wang-Gohrke, S, Webb, PM, White, E, Whittemore, AS, Winham, SJ, Wu, X, Wu, AH, Brand, Alison H., Yannoukakos, D, Spurdle, AB, O'Mara, TA, Brenton, James D., Brinton, Louise A., Bruinsma, Fiona, Buchanan, Daniel D., Aben, Katja K. H., Burghaus, S, Butzow, R, Cai, H, Carney, ME, Chanock, SJ, Chen, C, Chen, XQ, Chen, Z, Cook, LS, Cunningham, JM, Alsulimani, Ahmad, De Vivo, I, DeFazio, A, Doherty, JA, Dork, T, du Bois, A, Dunning, AM, Durst, M, Edwards, T, Edwards, RP, Ekici, AB, Amant, Frederic, Ewing, A, Fasching, PA, Ferguson, S, Flanagan, JM, Fostira, F, Fountzilas, G, Friedenreich, CM, Gao, B, Gaudet, MM, Gawelko, J, Annibali, Daniela, Gentry-Maharaj, A, Giles, GG, Glasspool, R, Goodman, MT, Gronwald, J, Harris, HR, Harter, P, Hein, A, Heitz, F, Hildebrandt, MAT, Attia, John, Hillemanns, P, Hogdall, E, Hogdall, CK, Holliday, Elizabeth G., Huntsman, DG, Huzarski, T, Jakubowska, A, Jensen, A, Jones, ME, Karlan, BY, Barricarte, Aurelio, Karnezis, A, Kelley, JL, Khusnutdinova, E, Killeen, JL, Kjaer, SK, Klapdor, R, Kobel, M, Konopka, B, Konstantopoulou, I, Kopperud, RK, Beckmann, Matthias W., Koti, M, Kraft, P, Kupryjanczyk, J, Lambrechts, D, Larson, MC, Le Marchand, L, Lele, S, Lester, J, Li, AJ, Liang, D, Berchuck, Andrew, Liebrich, C, Lipworth, L, Lissowska, J, Lu, L, Lu, KH, Macciotta, A, Mattiello, A, May, T, McAlpine, JN, McGuire, V

Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT⁺ cancers

- Roberts, Kathryn G., Smith, Amanda M., Sim, Alistair T. R., Ashman, Leonie K., Verrills, Nicole M., McDougall, Fiona, Carpenter, Helen, Horan, Martin, Neviani, Paolo, Powell, Jason A., Thomas, Daniel, Guthridge, Mark A., Perrotti, Danilo

Estrogen receptor expression in 21-gene recurrence score predicts increased late recurrence for estrogen-positive/HER2-negative breast cancer

- Dowsett, Mitch, Sestak, Ivana, Buus, Richard, Lopez-Knowles, Elena, Mallon, Elizabeth, Howell, Anthony, Forbes, John F., Buzdar, Aman, Cuzick, Jack

Exposure to diagnostic radiological procedures and the risk of childhood acute lymphoblastic leukemia

- Bailey, Helen D., Armstrong, Bruce K., De Klerk, Nicholas H., Fritschi, Lin, Attia, John R., Lockwood, Liane, Milne, Elizabeth, Aus-ALL Consortium,

Folate pathway gene polymorphisms and risk of childhood brain tumors: results from an Australian case-control study

- Greenop, Kathryn R., Scott, Rodney J., Ashton, Lesley J., Armstrong, Bruce K., Milne, Elizabeth, Attia, John, Bower, Carol, de Klerk, Nicholas H., Norris, Murray D., Haber, Michelle, Jamieson, Sarra E., van Bockxmeer, Frank M., Gottardo, Nicholas G.

Folate pathway gene polymorphisms, maternal folic acid use, and risk of childhood acute lymphoblastic leukemia

- Milne, Elizabeth, Greenop, Kathryn R., Dawson, Somer, McCowage, Geoffrey B., de Klerk, Nicholas H., van Bockxmeer, Frank M., Armstrong, Bruce K., Scott, Rodney J., Haber, Michelle, Norris, Murray D., Attia, John, Jamieson, Sarra E., Miller, Margaret, Bower, Carol, Bailey, Helen D.

Genetic ablation of the tetraspanin CD151 reduces spontaneous metastatic spread of prostate cancer in the TRAMP model

- Copeland, Ben T., Bowman, Matthew J., Ashman, Leonie K.